Team NB has finally published the long awaited template tripartite agreement for the transfer of surveillance activities of “legacy” medical devices.
The template was first referred to in a European Commission Q&A in March 2023 as a means of promoting consistency and certainty.
In the latest article, Alex Denoon and Vivien Zhu discuss the key factors of the template and provide insight into the initial feedback from clients.
Life Sciences Summit 2023:We will be hosting an evening of insightful discussions about the transformative potential of personalised medicine and the commercial, legal, and ethical barriers that lie in its way. Register your interest here. |
/Passle/5f3d6e345354880e28b1fb63/MediaLibrary/Images/2024-12-20-14-40-34-661-676581e2e237a0871914c367.png)
/Passle/5f3d6e345354880e28b1fb63/MediaLibrary/Images/2024-08-23-11-31-07-354-66c872fb971eecc249d83d40.png)
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-12-20-10-14-57-827-676543a18b3a544801097a93.jpg)